{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:41:52Z","timestamp":1790098912347,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated the effect of a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) agonist ophthalmic solution in wound healing using a rat corneal alkali burn model. After instillation of a selective agonist of PPAR\u03b1, fenofibrate, onto the burned cornea, PPAR\u03b1-positive cells were observed in vascular endothelial cells, and there was upregulation of mRNA of PPAR\u03b1 in corneal stroma. Fenofibrate suppressed expression of neutrophils and macrophages during the early phase, and development of neovascularization and myofibroblast generation during the late phase. Fenofibrate reduced not only mRNA expression of vascular endothelial growth factor-A but also angiopoietin-1 and angiopoietin-2. Furthermore, fenofibrate suppressed scar formation by reducing type III collagen expression. These data suggest that a PPAR\u03b1 agonist ophthalmic solution might be a new strategy for treating corneal wounds through not only anti-inflammatory effects but also by preventing neovascularization.<\/jats:p>","DOI":"10.1038\/s41598-017-18113-3","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T10:03:52Z","timestamp":1513159432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn"],"prefix":"10.1038","volume":"7","author":[{"given":"Takeshi","family":"Arima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"18113_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","volume":"68","author":"C Dreyer","year":"1992","unstructured":"Dreyer, C. et al. Control of the peroxisomal \u03b2-oxidation pathway by a novel family of nuclear hormone receptors. Cell. \n                           68, 879\u2013887 (1992).","journal-title":"Cell."},{"key":"18113_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","volume":"8","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. \n                           8, 1224\u20131234 (1994).","journal-title":"Genes Dev."},{"key":"18113_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/en.2003-0288","volume":"144","author":"CH Lee","year":"2003","unstructured":"Lee, C. H., Olson, P. & Evans, R. M. Minireview: Lipid Metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. \n                           144, 2201\u20132207 (2003).","journal-title":"Endocrinology."},{"key":"18113_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.ATV.0000015598.86369.04","volume":"22","author":"O Barbier","year":"2002","unstructured":"Barbier, O. et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. \n                           22, 717\u2013726 (2002).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"18113_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645a0","volume":"346","author":"I Issemann","year":"1990","unstructured":"Issemann, I. & Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. \n                           346, 645\u2013650 (1990).","journal-title":"Nature."},{"key":"18113_CR6","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1167\/iovs.13-13127","volume":"55","author":"E Moran","year":"2014","unstructured":"Moran, E. et al. Protective and antioxidant effects of PPAR\u03b1 in the ischemic retina. Invest Ophthalmol Vis Sci. \n                           55, 4568\u20134576, https:\/\/doi.org\/10.1167\/iovs.13-13127 (2014).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"18113_CR7","first-page":"1152","volume":"54","author":"Y Hu","year":"2013","unstructured":"Hu, Y. et al. The pathogenic role of down-regulation of PPAR-alpha expression in diabetic retinopathy. ARVO Meeting Abstracts. \n                           54, 1152 (2013).","journal-title":"ARVO Meeting Abstracts."},{"key":"18113_CR8","first-page":"1592","volume":"82","author":"DVC Marisol","year":"2008","unstructured":"Marisol, D. V. C. & Peter, L. G. PPAR-alpha ligands as potential therapeutic agents for wet age-related macular degeneration. PPAR Research. \n                           82, 1592 (2008).","journal-title":"PPAR Research."},{"key":"18113_CR9","first-page":"1518","volume":"20","author":"M Osada","year":"2014","unstructured":"Osada, M., Sakai, T., Kuroyanagi, K., Kohno, H. & Tsuneoka, H. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor \u03b1 agonist fenofibrate. Mol Vis. \n                           20, 1518\u20131526 (2014).","journal-title":"Mol Vis."},{"key":"18113_CR10","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.jmb.2013.05.010","volume":"425","author":"A Bernardes","year":"2013","unstructured":"Bernardes, A. et al. Molecular mechanism of peroxisome proliferator-activated receptor \u03b1 activation by WY14643: a new mode of ligand recognition and receptor stabilization. J Mol Biol. \n                           425, 2878\u20132893, https:\/\/doi.org\/10.1016\/j.jmb.2013.05.010 (2013).","journal-title":"J Mol Biol."},{"key":"18113_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ajpath.2011.10.006","volume":"180","author":"Y Nakamura","year":"2011","unstructured":"Nakamura, Y., Nakamura, T., Tarui, T., Inoue, J. & Kinoshita, S. Functional role of PPAR\u03b4 in corneal epithelial wound healing. Am J Pathol. \n                           180, 583\u2013598, https:\/\/doi.org\/10.1016\/j.ajpath.2011.10.006 (2011).","journal-title":"Am J Pathol."},{"key":"18113_CR12","first-page":"2135","volume":"19","author":"M Uchiyama","year":"2013","unstructured":"Uchiyama, M. et al. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. Mol Vis. \n                           19, 2135\u20132150 (2013).","journal-title":"Mol Vis."},{"key":"18113_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/01.RES.87.6.516","volume":"87","author":"H Lee","year":"2000","unstructured":"Lee, H. et al. Role for peroxisome proliferator-activated receptor \u03b1 in oxidized phospholipid\u2013induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res. \n                           87, 516\u2013521 (2000).","journal-title":"Circ Res."},{"key":"18113_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.taap.2011.02.012","volume":"252","author":"K Takahashi","year":"2011","unstructured":"Takahashi, K. et al. Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPAR\u03b1 deterioration. Toxicol Appl Pharmacol. \n                           252, 237\u2013249, https:\/\/doi.org\/10.1016\/j.taap.2011.02.012 (2011).","journal-title":"Toxicol Appl Pharmacol."},{"key":"18113_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1006\/bbrc.1998.8622","volume":"246","author":"I Inoue","year":"1998","unstructured":"Inoue, I., Shino, K., Noji, S., Awata, T. & Katayama, S. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem Biophys Res Commun. \n                           246, 370\u2013374 (1998).","journal-title":"Biochem Biophys Res Commun."},{"key":"18113_CR16","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/01.ATV.19.9.2094","volume":"19","author":"SM Jackson","year":"1999","unstructured":"Jackson, S. M. et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. \n                           19, 2094\u20132104 (1999).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"18113_CR17","unstructured":"Pfister, R. R. Alkali injuries of the eye (ed. Krachmer, J. H.) 1285\u20131293 (Elsevier Mosby, 2005)."},{"key":"18113_CR18","doi-asserted-by":"publisher","first-page":"e30842","DOI":"10.1371\/journal.pone.0030842","volume":"7","author":"L Yao","year":"2012","unstructured":"Yao, L. et al. Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PloS One. \n                           7, e30842, https:\/\/doi.org\/10.1371\/journal.pone.0030842 (2012).","journal-title":"PloS One."},{"key":"18113_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","volume":"61","author":"S Mandard","year":"2004","unstructured":"Mandard, S., M\u00fcller, M. & Kersten, S. Peroxisome proliferator-activated receptor target genes. Cell Mol Life Sci. \n                           61, 393\u2013416 (2004).","journal-title":"Cell Mol Life Sci."},{"key":"18113_CR20","doi-asserted-by":"publisher","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","volume":"274","author":"P Delerive","year":"1999","unstructured":"Delerive, P. et al. Peroxisome proliferator-activated receptor \u03b1 negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-\u03baB and AP-1. J Biol Chem. \n                           274, 32048\u201354 (1999).","journal-title":"J Biol Chem."},{"key":"18113_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1124\/mol.64.2.355","volume":"64","author":"JM Shipley","year":"2003","unstructured":"Shipley, J. M. & Waxman, D. J. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) \u03b1 and PPAR\u03b3. Mol Pharmacol. \n                           64, 355\u2013364 (2003).","journal-title":"Mol Pharmacol."},{"key":"18113_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1677\/joe.0.1690453","volume":"169","author":"P Delerive","year":"2001","unstructured":"Delerive, P., Fruchart, J. C. & Staels, B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol. \n                           169, 453\u2013459 (2001).","journal-title":"J Endocrinol."},{"key":"18113_CR23","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1017\/S1462399411001943","volume":"13","author":"TJ Koh","year":"2011","unstructured":"Koh, T. J. & DiPietro, L. A. Inflammation and wound healing: The role of the macrophage. Expert Rev Mol Med. \n                           13, e23, https:\/\/doi.org\/10.1017\/S1462399411001943 (2011).","journal-title":"Expert Rev Mol Med."},{"key":"18113_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout, A. L. et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. \n                           126, 789\u2013799 (2006).","journal-title":"Cell."},{"key":"18113_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0090-6980(00)00075-7","volume":"62","author":"ME Greene","year":"2000","unstructured":"Greene, M. E. et al. PPARgamma: observations in the hematopoietic system. Prostaglandins Other Lipid Mediat. \n                           62, 45\u201373 (2000).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"18113_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/wound.2012.0407","volume":"2","author":"A Sindrilaru","year":"2013","unstructured":"Sindrilaru, A. & Scharffetter-Kochanek, K. Disclosure of the culprits: macrophages-versatile regulators of wound healing. Adv Wound Care. \n                           2, 357\u2013368 (2013).","journal-title":"Adv Wound Care."},{"key":"18113_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0047-4","volume":"4","author":"PJ Wermuth","year":"2015","unstructured":"Wermuth, P. J. & Jimenez, S. A. The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases. Clin Transl Med. \n                           4, 2, https:\/\/doi.org\/10.1186\/s40169-015-0047-4 (2015).","journal-title":"Clin Transl Med."},{"key":"18113_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0161-6420(00)00289-X","volume":"107","author":"SC Brodovsky","year":"2000","unstructured":"Brodovsky, S. C. et al. Management of alkali burns: an 11-year retrospective review. Ophthalmology. \n                           107, 1829\u20131935 (2000).","journal-title":"Ophthalmology."},{"key":"18113_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00003226-199309000-00003","volume":"12","author":"S Saika","year":"1993","unstructured":"Saika, S., Kobata, S., Hashizume, N., Okada, Y. & Yamanaka, O. Epithelial basement membrane in alkali-burned corneas in rats: immunohistochemical study. Cornea. \n                           12, 383\u2013390 (1993).","journal-title":"Cornea."},{"key":"18113_CR30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0002-9440(10)62357-7","volume":"166","author":"S Saika","year":"2005","unstructured":"Saika, S. et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol. \n                           166, 1393\u20131403 (2005).","journal-title":"Am J Pathol."},{"key":"18113_CR31","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","volume":"171","author":"S Nakao","year":"2007","unstructured":"Nakao, S. et al. Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol. \n                           171, 1058\u20131065 (2007).","journal-title":"Am J Pathol."},{"key":"18113_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.1189704","volume":"18","author":"C Daly","year":"2004","unstructured":"Daly, C. et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. \n                           18, 1060\u20131071 (2004).","journal-title":"Genes Dev."},{"key":"18113_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/01.RES.83.3.233","volume":"83","author":"T Asahara","year":"1998","unstructured":"Asahara, T. et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res. \n                           83, 233\u2013240 (1998).","journal-title":"Circ Res."},{"key":"18113_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. \n                           277, 55\u201360 (1997).","journal-title":"Science."},{"key":"18113_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15252\/emmm.201505889","volume":"11","author":"JT Regula","year":"2016","unstructured":"Regula, J. T. et al. Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye disease. EMBO Mol Med. \n                           11, 1265\u20131288, https:\/\/doi.org\/10.15252\/emmm.201505889 (2016).","journal-title":"EMBO Mol Med."},{"key":"18113_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.exer.2014.08.001","volume":"133","author":"S Chen","year":"2015","unstructured":"Chen, S., Mienaltowski, M. J. & Birk, D. E. Regulation of corneal stroma extracellular matrix assembly. Exp Eye Res. \n                           133, 69\u201380 (2015).","journal-title":"Exp Eye Res."},{"key":"18113_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","volume":"49","author":"KM Meek","year":"2015","unstructured":"Meek, K. M. & Knupp, C. Corneal structure and transparency. Prog Retin Eye Res. \n                           49, 1\u201316, https:\/\/doi.org\/10.1016\/j.preteyeres.2015.07.001 (2015).","journal-title":"Prog Retin Eye Res."},{"key":"18113_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1679\/aohc.72.101","volume":"72","author":"S Inaga","year":"2009","unstructured":"Inaga, S. et al. Low vacuum scanning electron microscopy for paraffin sections utilizing the differential stainability of cells and tissues with platinum blue. Arch Histol Cytol. \n                           72, 101\u2013106 (2009).","journal-title":"Arch Histol Cytol."},{"key":"18113_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9440(10)61731-2","volume":"159","author":"Y Masuda","year":"2001","unstructured":"Masuda, Y. et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol. \n                           159, 599\u2013608 (2001).","journal-title":"Am J Pathol."},{"key":"18113_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10157-012-0637-z","volume":"16","author":"M Tanabe","year":"2012","unstructured":"Tanabe, M. et al. Development of lymphatic vasculature and morphological characterization in rat kidney. Clin Exp Nephrol. \n                           16, 833\u2013842, https:\/\/doi.org\/10.1007\/s10157-012-0637-z (2012).","journal-title":"Clin Exp Nephrol."},{"key":"18113_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1026468902409","volume":"29","author":"K Wakamatsu","year":"1997","unstructured":"Wakamatsu, K., Ghazizadeh, M., Ishizaki, M., Fukuda, Y. & Yamanaka, N. Optimizing collagen antigen unmasking in paraffin-embedded tissues. Histochem J. \n                           29, 65\u201372 (1997).","journal-title":"Histochem J."},{"key":"18113_CR42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.14712\/18059694.2019.168","volume":"41","author":"J Mokr\u00fd","year":"1998","unstructured":"Mokr\u00fd, J. & N\u0115mecek, S. Immunohistochemical detection of intermediate filament nestin. Acta Medica (Hradec Kralove) \n                           41, 73\u201380 (1998).","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"18113_CR43","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1097\/01.ASN.0000076078.50889.43","volume":"14","author":"K Matsui","year":"2003","unstructured":"Matsui, K. et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood. J Am Soc Nephrol. \n                           14, 1981\u20131989 (2003).","journal-title":"J Am Soc Nephrol."},{"key":"18113_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10157-014-1008-8","volume":"19","author":"Y Masuda","year":"2015","unstructured":"Masuda, Y. et al. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for 5 (IV) and 2 (IV) chains of type IV collagen and low-vacuum scanning electron microscopy. Clin Exp Nephrol. \n                           19, 427\u2013435, https:\/\/doi.org\/10.1007\/s10157-014-1008-8 (2015).","journal-title":"Clin Exp Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18113-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T16:47:16Z","timestamp":1671814036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18113-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["18113"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18113-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17763"}}